13D/13G Filings - ROTHBLATT MARTINE A

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-08
4:30 pm
Sale
2024-09-30 13G United Therapeutics Corporation
UTHR
ROTHBLATT MARTINE A 3,194,162
6.800%
-706,146decrease
(-18.10%)
Filing
History
2024-02-14
4:57 pm
Sale
2023-12-31 13G United Therapeutics Corporation
UTHR
ROTHBLATT MARTINE A 3,900,308
7.800%
-19,295decrease
(-0.49%)
Filing
History
2023-02-02
06:02 am
Sale
2022-12-31 13G United Therapeutics Corporation
UTHR
ROTHBLATT MARTINE A 3,919,603
8.000%
-198,884decrease
(-4.83%)
Filing
History
2022-02-04
4:31 pm
Purchase
2021-12-31 13G United Therapeutics Corporation
UTHR
ROTHBLATT MARTINE A 4,118,487
8.500%
489,001increase
(+13.47%)
Filing
History
2021-03-01
4:30 pm
Purchase
2020-12-31 13G United Therapeutics Corporation
UTHR
ROTHBLATT MARTINE A 3,629,486
7.600%
3,629,486increase
(New Position)
Filing
History